2019
DOI: 10.1007/s12020-019-01930-z
|View full text |Cite
|
Sign up to set email alerts
|

Novel high molecular weight albumin-conjugated angiotensin II activates β-arrestin and G-protein pathways

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 37 publications
0
5
0
Order By: Relevance
“…It is notable that the acute injection of these analogs induced excessive saline intake. 35-37 It is possible that the differences between these acute studies and our results in a chronic setting indicate that long-term activation of β-arrestins could induce distinct molecular signals that differ from the short-term effects. Indeed, it was reported that different biased agonists of the AT 1 R mediate subtly different intracellular signals.…”
Section: Discussionmentioning
confidence: 68%
“…It is notable that the acute injection of these analogs induced excessive saline intake. 35-37 It is possible that the differences between these acute studies and our results in a chronic setting indicate that long-term activation of β-arrestins could induce distinct molecular signals that differ from the short-term effects. Indeed, it was reported that different biased agonists of the AT 1 R mediate subtly different intracellular signals.…”
Section: Discussionmentioning
confidence: 68%
“…It is notable that other groups have reported that acute activation of β-arrestin using BSA-AngII or SII-Ang II promotes saline intake in rats. 83,84 It remains unclear what causes this discrepancy. Is it a species difference (mouse versus rat)?…”
Section: At 1 R β-Arrestin and Blood Pressurementioning
confidence: 99%
“…In Torres-Tirado et al (2013 ), the inverse ratio was established between the rate of AT1R internalization and desensitization from molecular mass of polymeric AngII-containing ligands. Based on the assumption that the high molecular weight ligand will be less susceptible to internalization, other authors ( Pang et al, 2019 ) studied the signaling properties of the chemically synthesized AngII-BSA peptide–protein complex, in which 10–12 molecules of AngII are bound to one BSA molecule. Such a ligand was developed as less capable of internalizing agonist supposedly inhibiting the ß-arrestin–biased pathway for signal transduction, which, as is known, is activated with the involvement of internalized AT1 ( Reiter et al, 2017 ).…”
Section: Opinionmentioning
confidence: 99%